Evidence map›Paper›PMID 39747958›Full record

ArticleScientific reports2025

PEGDA-based HistoBrick for increasing throughput of cryosectioning and immunohistochemistry in organoid and small tissue studies.

Emilie Vuille-Dit-Bille, Larissa Utz, Fiona E Müllner, Valeria J Arteaga-Moreta, Yanyan Hou, Stefan E Spirig, Diane Ledroit-Paic, Sarah Heub, Jonas Goldowsky, Gilles Weder and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. A novel phage encoding host defense modulators demonstrates in-vivo therapeutic efficacy against carbapenem-resistant E. coli ST1432.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Emilie Vuille-Dit-BilleCSEM SA, Neuchâtel, Switzerland. emilie.vuille-dit-bille@csem.ch.
Larissa UtzInstitute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland.
Fiona E MüllnerInstitute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland.
Valeria J Arteaga-MoretaInstitute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland.
Yanyan HouInstitute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland.
Stefan E SpirigInstitute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland.
Diane Ledroit-PaicCSEM SA, Neuchâtel, Switzerland.
Sarah HeubCSEM SA, Neuchâtel, Switzerland.
Jonas GoldowskyCSEM SA, Neuchâtel, Switzerland.
Gilles WederCSEM SA, Neuchâtel, Switzerland.
Magdalena RennerInstitute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland. magdalena.renner@iob.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histology is the gold standard for analyzing tissue structure and cell morphology. Immunostaining on thin tissue sections enables precise visualization of antigens and proteins. However, for cryosectioning small tissues such as organoids, spheroids, and tumoroids there is a lack of standardized, time- and cost-effective methods, limiting the throughput of analysis. Here, we have adapted to cryosectioning our previously developed HistoBrick approach, in which small tissue arrangement is spatially controlled within arrayed mini-wells. By testing various embedding matrices, we show that an 8% PEGDA and 2.5% gelatine mixture is optimal, providing essential structural support to maintain sample integrity during cryosectioning. This embedding matrix preserves fragile substructures of human retinal organoids, which are particularly susceptible to damage during sample preparation. Using PEGDA-gelatine HistoBricks for the simultaneous embedding of 16 retinal organoids, we analyzed a time course of retinal organoid development. We observed the maintenance of photoreceptors cell bodies up to week 98 in culture, while photoreceptor outer segments were gradually lost. Further, we observed displaced photoreceptors in the region of outer segments. The PEGDA-gelatine HistoBrick is a cost-efficient tool that can be implemented for small tissue studies to increase throughput in experiments such as large-scale screenings or toxicology research.

Indexed as

CryoultramicrotomyImmunohistochemistryOrganoidsPolyethylene GlycolsRetinaGelatinHumansGelatinPolyethylene Glycols3D cell modelsCryosectionHistoBrickHistologyHuman retinal organoidsMicrotissuesOrganoidsSpheroids

Identifiers

PMID39747958
PMCPMC11696907

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.